Richter Plc. (hereinafter: “Richter”) today announced that it has entered into
a distribution and supply agreement with a wholly owned subsidiary of Allergan
plc (hereinafter: “Allergan”) to commercialize its levonorgestrel releasing Intrauterine
System (IUS) in Latin American countries. The product is already marketed by
Richter under the trademark of LevosertTM since 2011 in most of
Europe through agreements established with Allergan.